Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] AREA[ConditionSearch] Anemia
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 … 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 Next Last
#
NCTID/Status
Study
Last Changed
101
NCT02522975
Recruiting
Recruiting
Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
Conditions: Renal Anaemia
Intervention: EPIAO®, EPREX®
Conditions: Renal Anaemia
Intervention: EPIAO®, EPREX®
April 27, 2018
102
NCT01995331
Unknown status
Unknown status
Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Conditions: Aplastic Anemia
Intervention: Cyclophosphamide,cyclosporine A
Conditions: Aplastic Anemia
Intervention: Cyclophosphamide,cyclosporine A
November 21, 2013
103
NCT03578419
Recruiting
Recruiting
Small-Volume Tubes to Reduce Anemia and Transfusion
Conditions: Blood Loss Anemia
Intervention: Small-Volume Blood Collection Tubes, Standard-Volume Blood Collection Tubes
Conditions: Blood Loss Anemia
Intervention: Small-Volume Blood Collection Tubes, Standard-Volume Blood Collection Tubes
April 18, 2019
104
NCT02565849
Completed
Completed
Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Conditions: Sickle Cell Anemia
September 30, 2015
105
NCT00822380
Completed
Completed
Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children
Conditions: Anemia
Intervention: Iron, Multiple Micronutrients Supplement, Micronutrient Fortified Porridge Powder, Iron And Ascorbic Acid Fortified Water, Iron Plus Folic Acid Supplement
Conditions: Anemia
Intervention: Iron, Multiple Micronutrients Supplement, Micronutrient Fortified Porridge Powder, Iron And Ascorbic Acid Fortified Water, Iron Plus Folic Acid Supplement
January 13, 2009
106
NCT02610881
Completed
Completed
Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children
Conditions: Anemia
Intervention: Iron And Folic Acid (IFA), Micronutrient Powders (MNP), Iron Plus Strategy Counseling
Conditions: Anemia
Intervention: Iron And Folic Acid (IFA), Micronutrient Powders (MNP), Iron Plus Strategy Counseling
April 22, 2016
107
NCT02745717
Recruiting
Recruiting
The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia
Intervention: Thymoglobulin, Cord Blood, Cyclosporine Oral Product
Conditions: Severe Aplastic Anemia
Intervention: Thymoglobulin, Cord Blood, Cyclosporine Oral Product
September 8, 2018
108
NCT01131624
Completed
Completed
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Conditions: Anaemia
Intervention: Ferrous Sulphate, Ferinject
Conditions: Anaemia
Intervention: Ferrous Sulphate, Ferinject
May 27, 2015
109
NCT02569515
Completed
Completed
A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia
Conditions: Anemia
Intervention: Epoetin Beta
Conditions: Anemia
Intervention: Epoetin Beta
November 1, 2016
110
NCT02656225
Unknown status
Unknown status
Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome
Conditions: Postpartum Anemia
Intervention: Ejiao Compound, Niferex
Conditions: Postpartum Anemia
Intervention: Ejiao Compound, Niferex
March 25, 2016
111
NCT00498511
Unknown status
Unknown status
Gastrointestinal Evaluation in Young Men With Iron Deficiency Anemia
Conditions: Anemia, Iron-Deficiency
Intervention: Upper Gastrointestinal Endoscopy, Colonoscopy
Conditions: Anemia, Iron-Deficiency
Intervention: Upper Gastrointestinal Endoscopy, Colonoscopy
July 12, 2007
112
NCT02467257
Completed
Completed
Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Intervention: Gum Arabic
Conditions: Sickle Cell Anemia
Intervention: Gum Arabic
June 5, 2015
113
NCT01873534
Terminated
Terminated
A Phase 2A Trial of FMX-8 Treatment for Anemia in Patients With ESRD on Hemodialysis HD
Conditions: Anemia of Chronic Disease
Intervention: FMX-8
Conditions: Anemia of Chronic Disease
Intervention: FMX-8
July 21, 2015
114
NCT01506726
Terminated
Terminated
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
Conditions: Anemia
Intervention: Salsalate, Placebo
Conditions: Anemia
Intervention: Salsalate, Placebo
August 31, 2016
115
NCT00213161
Completed
Completed
Using Iron Supplementation to Decrease Iron Deficiency Anemia in Infants and Young Children in India
Conditions: Anemia
Intervention: Iron Supplement, Iron Drops
Conditions: Anemia
Intervention: Iron Supplement, Iron Drops
October 10, 2006
116
NCT00478582
Completed
Completed
Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
Conditions: Anemia
Intervention: Estimation Of Hb Concentrations With The HemoHue Card
Conditions: Anemia
Intervention: Estimation Of Hb Concentrations With The HemoHue Card
January 12, 2011
117
NCT00630253
Recruiting
Recruiting
Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
Conditions: Fanconi Anemia
Intervention: Anti-Thymocyte Globulin, Cyclophosphamide, Fludarabine, Hematopoietic Stem Cell Transplantation, Methylprednisolone, Filgrastim, Cyclosporine, Mycophenolate Mofetil
Conditions: Fanconi Anemia
Intervention: Anti-Thymocyte Globulin, Cyclophosphamide, Fludarabine, Hematopoietic Stem Cell Transplantation, Methylprednisolone, Filgrastim, Cyclosporine, Mycophenolate Mofetil
January 6, 2020
118
NCT02769845
Active, not recruiting
Active, not recruiting
SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea, TCD Examination
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea, TCD Examination
January 6, 2020
119
NCT02918292
Recruiting
Recruiting
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Conditions: Severe Aplastic Anemia
Intervention: Antithymocyte Globulin (ATG), Fludarabine, Cyclophosphamide, Total Body Irradiation (TBI), Haplo HSCT, Tacrolimus, Mycophenolate Mofetil (MMF), G-CSF
Conditions: Severe Aplastic Anemia
Intervention: Antithymocyte Globulin (ATG), Fludarabine, Cyclophosphamide, Total Body Irradiation (TBI), Haplo HSCT, Tacrolimus, Mycophenolate Mofetil (MMF), G-CSF
December 9, 2019
120
NCT00578266
Completed
Completed
Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Conditions: Anemia, Aplastic
Intervention: Cyclophosphamide,Campath IH And TBI
Conditions: Anemia, Aplastic
Intervention: Cyclophosphamide,Campath IH And TBI
March 23, 2017
121
NCT03633604
Available
Available
Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia
Conditions: Anemia Severe
Intervention: HBOC-201
Conditions: Anemia Severe
Intervention: HBOC-201
July 10, 2019
122
NCT02037724
Unknown status
Unknown status
Fermented Iron-rich Supplement in Reducing Anemia
Conditions: Iron Deficiency Anemia
Intervention: Supplement Containing 60 Mg Iron Sulfate, Iron Rich Food Supplement (60 Mg Iron), Iron Rich Food Supplement (10 Mg Iron), Supplement Containing 10 Mg Iron Sulfate
Conditions: Iron Deficiency Anemia
Intervention: Supplement Containing 60 Mg Iron Sulfate, Iron Rich Food Supplement (60 Mg Iron), Iron Rich Food Supplement (10 Mg Iron), Supplement Containing 10 Mg Iron Sulfate
January 14, 2014
123
NCT00740246
Completed
Completed
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
Conditions: Anemia
Intervention: VIT-45
Conditions: Anemia
Intervention: VIT-45
August 21, 2008
124
NCT01071239
Completed
Completed
Hematopoietic Stem Cell Transplant for Fanconi Anemia
Conditions: Fanconi Anemia
Intervention: CliniMACs Device, Busulfan, Fludarabine, Cyclophosphamide, ATG
Conditions: Fanconi Anemia
Intervention: CliniMACs Device, Busulfan, Fludarabine, Cyclophosphamide, ATG
September 3, 2019
125
NCT03666806
Active, not recruiting
Active, not recruiting
Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial
Conditions: Preventing Stroke in Sickle Cell Anaemia
Intervention: Influenza Vaccine
Conditions: Preventing Stroke in Sickle Cell Anaemia
Intervention: Influenza Vaccine
September 10, 2018
126
NCT00672789
Completed
Completed
Adherence to Hydroxyurea in Children With Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Intervention: Blood Smear Education, Standard Education
Conditions: Sickle Cell Anemia
Intervention: Blood Smear Education, Standard Education
May 24, 2013
127
NCT01129323
Withdrawn
Withdrawn
Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia
Intervention: Cyclophosphamide, Fludarabine, Rabbit ATG
Conditions: Severe Aplastic Anemia
Intervention: Cyclophosphamide, Fludarabine, Rabbit ATG
March 23, 2012
128
NCT02961218
Active, not recruiting
Active, not recruiting
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Intervention: Ilaris, Canakinumab, Placebo
Conditions: Sickle Cell Anemia
Intervention: Ilaris, Canakinumab, Placebo
October 28, 2019
129
NCT04069533
Recruiting
Recruiting
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
Conditions: Fanconi Anemia Complementation Group A
Intervention: RP-L102
Conditions: Fanconi Anemia Complementation Group A
Intervention: RP-L102
January 24, 2020
130
NCT02028416
Unknown status
Unknown status
Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Conditions: Aplastic Anemia
Intervention: ATG-fresenius
Conditions: Aplastic Anemia
Intervention: ATG-fresenius
April 3, 2016
131
NCT00704028
Completed
Completed
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia
Conditions: Anemia
Intervention: Ferric Carboxymaltose, Iron Dextran
Conditions: Anemia
Intervention: Ferric Carboxymaltose, Iron Dextran
January 22, 2018
132
NCT02090296
Withdrawn
Withdrawn
Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea, Placebo
Conditions: Sickle Cell Anemia
Intervention: Hydroxyurea, Placebo
October 16, 2017
133
NCT00703937
Completed
Completed
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
Conditions: Anemia
Intervention: Ferric Carboxymaltose (FCM), Standard Medical Care (SMC) For The Treatment Of IDA
Conditions: Anemia
Intervention: Ferric Carboxymaltose (FCM), Standard Medical Care (SMC) For The Treatment Of IDA
January 22, 2018
134
NCT00326417
Completed
Completed
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
Conditions: Anemia, Aplastic
Intervention: Fludarabine, Cyclophosphamide 150mg, Cyclophosphamide 100mg, Cyclophosphamide 50mg
Conditions: Anemia, Aplastic
Intervention: Fludarabine, Cyclophosphamide 150mg, Cyclophosphamide 100mg, Cyclophosphamide 50mg
September 27, 2017
135
NCT00701246
Completed
Completed
Treatment and Prevention of Anemia With Ferrous Sulfate Plus Folic Acid in Children in Goiania - Goias, Brazil
Conditions: Anemia
Intervention: Ferrous Sulfate, Folic Acid, Placebo (folic Acid)
Conditions: Anemia
Intervention: Ferrous Sulfate, Folic Acid, Placebo (folic Acid)
March 12, 2014
136
NCT01267643
Terminated
Terminated
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Conditions: Aplastic Anemia
Intervention: Alefacept
Conditions: Aplastic Anemia
Intervention: Alefacept
January 24, 2018
137
NCT00258427
Recruiting
Recruiting
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Conditions: Fanconi Anemia
Intervention: Anti-thymocyte Globulin, Filgrastim, Busulfan, Cyclophosphamide, Fludarabine Phosphate, Methylprednisolone, Hematopoietic Stem Cell Transplantation
Conditions: Fanconi Anemia
Intervention: Anti-thymocyte Globulin, Filgrastim, Busulfan, Cyclophosphamide, Fludarabine Phosphate, Methylprednisolone, Hematopoietic Stem Cell Transplantation
January 27, 2020
138
NCT00704353
Completed
Completed
Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
Conditions: Anemia
Intervention: Ferric Carboxymaltose, Standard Medical Care (SMC)
Conditions: Anemia
Intervention: Ferric Carboxymaltose, Standard Medical Care (SMC)
January 22, 2018
139
NCT01408342
Withdrawn
Withdrawn
Alemtuzumab and Rituximab in Aplastic Anemia
Conditions: Aplastic Anemia
Intervention: Alemtuzumab And Rituximab
Conditions: Aplastic Anemia
Intervention: Alemtuzumab And Rituximab
January 3, 2014
140
NCT00578903
Terminated
Terminated
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Conditions: Aplastic Anemia
Intervention: Cytoxan, Campath, Total Body Irradiation (TBI), FK-506, Methotrexate, Stem Cell Infusion
Conditions: Aplastic Anemia
Intervention: Cytoxan, Campath, Total Body Irradiation (TBI), FK-506, Methotrexate, Stem Cell Infusion
March 24, 2016
141
NCT00236951
Completed
Completed
Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy
Conditions: Anemia
Intervention: Iron Sucrose Injection USP, Stable Erythropoietin Therapy
Conditions: Anemia
Intervention: Iron Sucrose Injection USP, Stable Erythropoietin Therapy
January 22, 2018
142
NCT01414374
Completed
Completed
Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
Conditions: Iron Deficiency Anemia
Intervention: Herbal Medicine, Iron
Conditions: Iron Deficiency Anemia
Intervention: Herbal Medicine, Iron
February 12, 2015
143
NCT00317876
Completed
Completed
Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia
Conditions: Fanconi Anemia
Intervention: Cyclophosphamide, Cyclosporine, Methotrexate, Allogeneic Bone Marrow Transplantation, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: Fanconi Anemia
Intervention: Cyclophosphamide, Cyclosporine, Methotrexate, Allogeneic Bone Marrow Transplantation, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
April 18, 2012
144
NCT04001686
Recruiting
Recruiting
Ambispective Observational Study to Evaluate the Incidence and Management of Aplastic Anemia in Spain
Conditions: Aplastic Anemia
Intervention: Incidence Aplastic Anemia
Conditions: Aplastic Anemia
Intervention: Incidence Aplastic Anemia
June 26, 2019
145
NCT04045002
Not yet recruiting
Not yet recruiting
'MyPinkMom' Educational Intervention for Pregnant Women With Anaemia
Conditions: Anaemia in Pregnancy
Intervention: 'MyPinkMom' Educational Intervention
Conditions: Anaemia in Pregnancy
Intervention: 'MyPinkMom' Educational Intervention
October 8, 2019
146
NCT03896971
Recruiting
Recruiting
Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia
Conditions: Aplastic Anemia
Intervention: Combination Of Thrombopoietin Mimetic And Cyclosporin A
Conditions: Aplastic Anemia
Intervention: Combination Of Thrombopoietin Mimetic And Cyclosporin A
June 13, 2019
147
NCT03657433
Recruiting
Recruiting
Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
Conditions: Iron Deficiency Anemia of Pregnancy
Intervention: Ferrous Sulfate 325mg, Ferumoxytol
Conditions: Iron Deficiency Anemia of Pregnancy
Intervention: Ferrous Sulfate 325mg, Ferumoxytol
November 25, 2019
148
NCT03025698
Recruiting
Recruiting
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
Conditions: Aplastic Anemia
Intervention: Eltrombopag, HATG, CsA
Conditions: Aplastic Anemia
Intervention: Eltrombopag, HATG, CsA
January 13, 2020
149
NCT00992823
Completed
Completed
Iron Supplementation to Reduce Preschoolers Anemia: Comparison Between Intermittent and Cyclic Procedure
Conditions: Anemia
Intervention: Iron Supplementation, Iron Supplementation
Conditions: Anemia
Intervention: Iron Supplementation, Iron Supplementation
October 14, 2009
150
NCT01788631
Completed
Completed
A Phase II Trial of Regadenoson in Sickle Cell Anemia
Conditions: Sickle Cell Anemia
Intervention: Regadenoson, Placebo
Conditions: Sickle Cell Anemia
Intervention: Regadenoson, Placebo
January 10, 2018
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 … 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.